Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2017-02-23

FDA Approved: PERPHENAZINE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental labeling application for PERPHENAZINE from Sandoz Inc, resulting in updates to the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PERPHENAZINE (Perphenazine)

Snippet

SUPPL AP for PERPHENAZINE (PERPHENAZINE)